Core Insights - The article highlights Alan Brochstein's extensive experience in the investment industry, particularly his focus on the cannabis sector since 2014 [1] - It emphasizes the importance of ETFs in enabling diversified investment portfolios for both individual and institutional investors [1] - The article mentions Brochstein's efforts to educate investors about the ETF landscape and the associated risks [1] Group 1: Professional Background - Alan Brochstein has been contributing to Seeking Alpha since 2007 and has a background in both sell-side and buy-side roles in fixed-income and equities [1] - He founded AB Analytical Services in 2007 to provide independent consulting to registered investment advisors [1] - Brochstein has been a pioneer in the cannabis investment space, launching 420 Investor in 2013, a subscription service focused on cannabis stocks [1] Group 2: ETF Focus - Brochstein has been writing extensively about ETFs since 2025, aiming to help investors understand the ETF universe [1] - He maintains a 79-ETF Focus List that includes both popular and lesser-known ETFs that he believes stand out [1] - A model portfolio was created by Brochstein as of year-end 2025 to assist investors in managing their ETF investments [1]

Core Insights - Cannara Biotech Inc. reported strong financial results for Q1 2026, with total revenues of $30.1 million, a 20% increase from $25.1 million in Q1 2025, driven by market share expansion and improved operational efficiency [5][8][12] - The company achieved a gross profit before fair value adjustments of $13.5 million, representing a 38% increase year-over-year, and an adjusted EBITDA of $8.8 million, up 47% compared to the same period last year [5][8][12] - Cannara's national retail market share reached 4.1% in Q1 2026, up from 3.8% in Q4 2025, with significant gains in key provinces, particularly Québec and Ontario [5][10][20] Financial Performance - Gross cannabis revenues before excise taxes increased to $41.8 million in Q1 2026 from $34.9 million in Q1 2025, a $6.9 million or 20% increase [8][12] - Total revenues, net of excise taxes, rose to $30.1 million in Q1 2026 from $25.1 million in Q1 2025, reflecting a $5.0 million or 20% increase [5][8] - Gross profit before fair value adjustments increased to $13.5 million in Q1 2026, up 38% from $9.8 million in Q1 2025, with a gross profit percentage of 45% [8][26] Operational Highlights - Cannara's operational strategy focuses on disciplined expansion, with the Valleyfield processing center on track for completion in Fiscal 2026 and three additional grow zones being prepared for Fiscal 2027 [5][12][11] - The company reported strong operating cash flow of $8.0 million in Q1 2026, supporting its capital allocation strategy [5][12] - The launch of new products, including vape cartridges, contributed to market share gains and brand recognition [13][15] Market Share Insights - The estimated national retail market share of Cannara increased to 4.1% in Q1 2026, with notable growth in Québec, where the company ranked 1 by December 2025 [5][10][20] - In comparison to Q1 2025, Cannara's market share in Québec rose to 13.5% from 12.5%, and in Ontario, it increased to 3.1% from 2.6% [21][23] - The company experienced a decrease in market share in Saskatchewan, down to 0.9% from 1.7% in Q1 2025, while Manitoba saw an increase to 1.4% from 0.9% [21][23]

Core Insights - Village Farms International, Inc. has been awarded the 2026 BC Export Award in the Consumer Products category, highlighting its significant export performance and contribution to British Columbia's international trade economy [1] Group 1: Export Performance - The company achieved a 758% year-over-year increase in export sales as of September 30, 2025, driven by disciplined, market-specific growth strategies and regulatory compliance expertise [2] - Village Farms operates a 4.8 million square foot production campus that is EU-GMP certified, allowing it to scale international exports to highly regulated markets [2] Group 2: Operational Excellence - The company's success in international markets is attributed to its commitment to rigorous operational standards and treating regulation as an opportunity for sustainable performance [3] - Village Farms is one of the largest single-site agricultural employers in British Columbia, supporting hundreds of jobs and maintaining a competitive export platform [3] Group 3: Market Strategy - The company has established strong demand for its products in large European markets, particularly Germany, where its cultivars rank among the top-performing medical cannabis strains [3] - Village Farms is expanding its export business to new countries and customers while making investments in international production assets [8] Group 4: Future Growth - The company owns 2.6 million square feet of greenhouse capacity in Canada for future expansion and is targeting legal cannabis opportunities internationally [6][8] - In the U.S., Village Farms plans to enter the THC market leveraging its existing greenhouse assets and land for future expansion [9]

Caribbean cannabis growers eye budding domestic sales and exports https://t.co/IKeLwMerPN ...

Group 1: Market Overview - Cannabis stocks to watch include Tilray Brands, Canopy Growth, Aurora Cannabis, Silver Spike Investment, and Cronos Group, identified by MarketBeat's stock screener tool [2] - Cannabis stocks are characterized by higher regulatory and legal risks, and they tend to be more volatile than the broader market due to changing laws and consumer demand [2] Group 2: Company Profiles - **Tilray Brands (TLRY)**: Engages in research, cultivation, processing, and distribution of medical cannabis, operating in multiple countries including Canada, Australia, and Germany [3] - **Canopy Growth (CGC)**: Involved in the production, distribution, and sale of cannabis and hemp-based products, primarily in the U.S., Canada, and Germany, with operations segmented into Canada Cannabis and International Markets Cannabis [3] - **Aurora Cannabis (ACB)**: Produces and sells cannabis products in Canada and internationally, operating through Canadian Cannabis, European Cannabis, and Plant Propagation segments [4] - **Silver Spike Investment (SSIC)**: A specialty finance company that invests in the cannabis ecosystem through direct loans and equity ownership of privately held cannabis companies [4] - **Cronos Group (CRON)**: Engages in the cultivation and marketing of cannabis products in Canada, Israel, and Germany, offering a variety of products under several brands [5]

Core Insights - The cannabis industry is experiencing significant regulatory changes and stock volatility, with expectations for long-term growth due to increased acceptance of marijuana for medical and recreational use [1][2][3] Industry Overview - The current investing landscape in the cannabis sector is shaped by regulatory reforms, which are crucial for understanding market dynamics and potential investment opportunities [2] - Speculation plays a significant role in trading, and 2026 is anticipated to be a pivotal year for legal cannabis, with high hopes for market performance [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, involved in cultivation, processing, and distribution of cannabis products. The company recently praised the Trump administration for rescheduling cannabis to Schedule 3, marking a significant milestone in cannabis reform [4][6][7] - **Curaleaf Holdings, Inc.**: Engages in the production and distribution of cannabis products both domestically and internationally. The company recently launched Adult Use sales in Maine, expanding its retail presence to five locations in the state and 161 nationwide [9][10]

Core Insights - U.S. equities have seen a decline in dominance, with valuation gaps narrowing from 54% above global peers at the end of 2024 to about 42% by mid-April 2025, indicating a potential shift in market leadership [2] - J.P. Morgan's forward-looking estimates suggest that developed international markets, including Canada, could outperform U.S. equities over the next decade, with projected annual returns of 8.1% for EAFE markets compared to 6.7% for the U.S. [3] - Canadian equities provide diversification benefits, reducing reliance on U.S. mega-cap stocks while offering exposure to various economic drivers such as commodities and energy [4] Canadian Stocks Overview - A list of 10 high-growth Canadian stocks has been compiled, focusing on companies with over 20% revenue growth in the past five years [5][7] - The methodology involved using the Finviz stock screener and analyzing hedge fund sentiment from Insider Monkey's database as of Q3 2025 [7][8] Draganfly Inc. (NASDAQ:DPRO) - Draganfly Inc. has achieved a 5-year revenue growth of 35.71% and has 6 hedge fund holders [9] - The company reported Q3 2025 revenue of $2.155 million, a 14.4% year-over-year increase, with strong demand in defense and public safety markets [10] - Draganfly is expanding its commercial footprint through partnerships and has integrated its drones with advanced detection systems for search-and-rescue missions [11][12] Cronos Group Inc. (NASDAQ:CRON) - Cronos Group has a 5-year revenue growth of 37.71% and is supported by 16 hedge fund holders [13] - The company reported consolidated net revenue of $36.3 million in Q3 2025, a 6% year-over-year increase, driven by the success of its Spinach brand [14] - Cronos maintains a strong balance sheet with no debt and approximately $824 million in cash and equivalents, positioning it well within the cannabis industry [13][15]

Industry Overview - The cannabis industry is expected to see significant developments by 2026, particularly in the U.S. where cannabis is now classified as a Class 3 substance, leading to potential regulatory changes and new business opportunities [1][2] - The success of cannabis companies is closely tied to their ability to expand operations and meet the growing demand for cannabis products as societal acceptance increases [2][3] Company Highlights - **Glass House Brands Inc.**: This integrated cannabis company operates in three segments: Retail, Wholesale Biomass, and Cannabis-Related Consumer Packaged Goods. The company has announced an accelerated expansion strategy for 2026, driven by positive results from previous developments and anticipated cannabis reform [4][6] - **Verano Holdings Corp.**: A vertically integrated multi-state cannabis operator that has recently increased its revolving credit facility by $100 million, extending its maturity date without additional collateral. This move is part of a strategy to strengthen its balance sheet [9][10] - **Planet 13 Holdings Inc.**: This company cultivates and provides cannabis products for both medical and retail markets. At the start of 2026, it granted Restricted Stock Units (RSUs) to its officers, directors, and employees, which will vest in three equal tranches [12]

Core Viewpoint - The AdvisorShares Pure Cannabis ETF (YOLO) is an actively managed exchange-traded fund aimed at providing investors with global exposure to the cannabis industry [1] Group 1: Fund Overview - YOLO is designed to invest in companies operating within the cannabis sector on a global scale [1] Group 2: Analyst Background - Michael Del Monte is a buy-side equity analyst with over a decade of experience in various sectors including technology, energy, and industrials [1]

Acquisition and Strategic Expansion - Simply Solventless Concentrates Ltd. (SSC) has announced the acquisition of Uncommon Cannabis Co., a dried flower and preroll brand, which is expected to enhance SSC's market presence and revenue streams [2][3][7] - The acquisition will allow SSC to enter the Canadian recreational dried flower and regular preroll markets, complementing its existing B2B sales channels [3][7] - Uncommon generated approximately $1.8 million in gross revenue during 2025, primarily through third-party sales, with 65% of its revenue coming from the Quebec market [4][7] Financial Strengthening - SSC has entered into an agreement to convert $1.0 million of promissory notes to equity at $0.20 per unit, significantly improving its balance sheet [2][28][31] - The purchase price for Uncommon is approximately $200,000 net of working capital, which includes around $100,000 in net working capital [8][9] Sales Performance and Growth Strategy - SSC's retail CPG sales velocity has increased from approximately $0.6 million per week to $1.0 million per week over the past two fiscal years, indicating strong growth potential [13][11] - The company has identified areas for improvement and is implementing a robust commercial plan to achieve meaningful growth across several product categories [12][13] Brand Strategy and Portfolio Realignment - SSC is undergoing a structural realignment of its brand strategy to enhance focus and execution, particularly for its legacy brands that have faced performance pressure [23][25] - The company aims to simplify its brand portfolio, ensuring each brand has a defined consumer target and strategic purpose, supported by a strong sales team [24][27] Market Position and Future Outlook - The acquisition of Uncommon is expected to accelerate SSC's entry into new markets and provide an existing revenue stream, which is crucial for the company's growth strategy [7][11] - SSC's President & CEO expressed optimism about the company's outlook for 2026, highlighting the importance of developing adequate markets and sales channels for increased production [11][31]